The aim of this work was to develop a selective method for quantification of Sn(II) and Sn(IV) in dimercaptosuccinic acid (DMSA), ethylcysteinate dimer (ECD), methylenediphosphonic acid (MDP), and pyrophosphate radiopharmaceutical cold kits by differential pulse polarography. Methods: A dripping mercury electrode 150 polarographic/stripping analyzer with a conventional 3-electrode configuration was used with 3 M H 2 SO 4 and 3 M HCl supporting electrolytes for Sn(II) and Sn(IV), respectively. The polarographic analysis was performed using a 1-s drop time, 50-mVÁs 21 scan rate, 250-mV pulse amplitude, 40-ms pulse time, and 10-mV step amplitude. To quantify Sn(IV), oxidation of Sn(II) by H 2 O 2 was performed. The calibration curves for Sn (II) and Sn(IV) were obtained in the range of 0-10 mgÁmL 21 . Results: The analytic curves for Sn(II) in 3 M H 2 SO 4 and Sn(IV) in 3 M HCl were represented by the following equations: i (mA) 5 0.098 [Sn(II)] 1 0.018 (r 2 5 0.998) and i (mA) 5 0.092 [Sn(IV)] 1 0.016 (r 2 5 0.998), respectively. The detection limits were 0.21 mgÁmL 21 for Sn(II) and 0.15 mgÁmL 21 for Sn(IV). In DMSA, ECD, MDP, and pyrophosphate, 90.0%, 64.9%, 93.2%, and 87.5%, respectively, of the tin was present as Sn(II). In this work, selective determination of Sn(II) and Sn(IV) was achieved using 2 supporting electrolytes (H 2 SO 4 and HCl). In 3 M H 2 SO 4 , only Sn(II) produced a polarographic wave with the maximum current in 2370 mV. Under the same conditions, no current could be determined for Sn(IV). In 3 M HCl, Sn(II) and Sn(IV) were electroactive and the maximum currents of the 2 waves appeared in 2250 and 2470 mV. No other components of the lyophilized reagents had any influence. Conclusion: The developed polarographic method was adequate to quantify Sn(II) and Sn(IV) in DMSA, ECD, MDP, and pyrophosphate cold kits. Radi opharmaceutical cold kits for labeling with 99m Tc contain Sn(II) for reduction of technetium to lower oxidation states that are chemically reactive to specific ligands. Besides these ligands, the cold kits usually contain stannous chloride (SnCl 2 ) and different additives (complexing agents, antioxidants, and buffers). The amount of stannous ions varies (0.03-1.5 mg of SnCl 2 ), although a minimum concentration must be present to guarantee the lyophilized reagent shelf life and to allow efficient labeling with 99m Tc (1).
Radi opharmaceutical cold kits for labeling with 99m Tc contain Sn(II) for reduction of technetium to lower oxidation states that are chemically reactive to specific ligands. Besides these ligands, the cold kits usually contain stannous chloride (SnCl 2 ) and different additives (complexing agents, antioxidants, and buffers). The amount of stannous ions varies (0.03-1.5 mg of SnCl 2 ), although a minimum concentration must be present to guarantee the lyophilized reagent shelf life and to allow efficient labeling with 99m Tc (1) .
Depending on the medium composition, Sn(II) ions in low-concentration solutions (,2.0Á10 24 M) are oxidized, and the formation of basic complexes takes place above pH 2.00 (2, 3) . The quantitative determination of Sn(II) in radiopharmaceutical cold kits is an important aspect of quality control, and the analytic method must be accurate even in the presence of Sn(IV) ions (4) .
Such techniques as colorimetry, titrimetry, spectrophotometry, voltammetry, and polarography have been described in the literature for Sn(II) determination in cold kits (5) (6) (7) (8) (9) (10) (11) (12) .
Zimmer et al. studied the formation of a red porphyrin complex in the presence of Sn(II) ions using a colorimetric method. The time of the color fading was proportional to the Sn(II) concentration in pyrophosphate, methylenediphosphonic acid (MDP), and diethylenetriaminepentaacetic acid (DTPA) (5). Chervu et al. have used a potentiometric titration of Sn(II) in HCl and potassium iodate as the oxidizing agent to analyze DTPA, glucoheptonate, hepatoiminodiacetic acid, MDP, and pyrophosphate (6). Muddukrishna et al. developed a method based on the oxidation of Sn(II) using a known excess of iodate or iodine, and the unreacted excess of the oxidizing agent was titrated with thiosulfate in glucoheptonate, hepatoiminodiacetic acid, MDP, DTPA, human serum albumin, albumin macroaggregate, and pyrophosphate. The procedure was used to overcome the need to perform experiments in an oxygen-free atmosphere as required by the direct iodometric titration. Reducing agents such as ascorbic acid and human serum albumin interfered with this method (7).
Mushtaq et al. have proposed a method in which the amount of Sn(II) in various cold kits was determined by a spectrophotometric method using palladium chloride. This method was not applicable to dimercaptosuccinic acid (DMSA), DTPA, ethylcysteinate dimer (ECD), or methoxyisobutyl isonitrile because of ligand or antioxidant interference (8). Boutakhrit et al. determined Sn(II) ions in DMSA by flow injection analysis with amperometric detection. Metal ions did not influence the signal of the Sn(II)-8-hydroxyquinoline complex and ascorbic acid, but medronic acid, 4-aminobenzoic acid, and pentetic acid increased or decreased the peak (9) .
Polarographic analysis has been used as an alternative method in which the main advantage is the differentiation between Sn(II) and Sn(IV) ions. On a hanging drop of mercury, a redox process occurs, and a current proportional to the amount of the species taking part in the electrochemical reaction is measured (13, 14) .
Polarographic (16) .
The aim of this work was to develop a selective method for the determination of Sn(II) and Sn(IV) (total tin) in DMSA, ECD, MDP, and pyrophosphate radiopharmaceutical cold kits.
MATERIALS AND METHODS

Apparatus
The polarographic analysis was performed using a dripping mercury electrode 150 polarographic/stripping analyzer (Radiometer Analytic), with a conventional 3-electrode configuration consisting of a static mercury drop electrode, an AgCl/ Ag (saturated KCl) reference electrode, and a platinum wire auxiliary electrode. The experimental conditions were a 1-s drop time, 50-mVÁs 21 scan rate, 250-mV pulse amplitude, 40-ms pulse time, and 10-mV step amplitude.
Reagents and Solutions
DMSA, ECD, MDP, and pyrophosphate radiopharmaceutical cold kits were from IPEN-CNEN/SP. The formulations were DMSA (1 mg) and SnCl 2 Á2H 2 O (0.41 mg); ECD (1 mg), mannitol (24 mg), ethylenediamine tetraacetic acid (0.36 mg), and SnCl 2 Á2H 2 O (0.125 mg); MDP (5 mg), ascorbic acid (0.10 mg), pyrophosphate (45 mg), and SnCl 2 Á2H 2 O (1 mg); and pyrophosphate (10 mg) and SnCl 2 Á2H 2 O (2 mg).
SnCl 2 Á2H 2 O and a 1,000 mgÁmL 21 standard solution of Sn(IV) were pro analysi grade, and H 2 O 2 , H 2 SO 4 , and HCl were super-pure reagents from Merck. Purified water obtained from an Elix 10 system (Millipore) was used to prepare all the solutions. A stock solution of Sn(II) (1,000 mgÁmL 21 ) was prepared just before analysis by adding SnCl 2 Á2H 2 O in nitrogen-deaerated 1.0 M HCl solution.
Procedure
A supporting electrolyte (10 mL) was initially added to the polarographic cell and deaerated with nitrogen gas for 5 min. The supporting electrolytes for Sn(II) and Sn(IV) determinations were 3 M H 2 SO 4 and 3 M HCl, respectively. A differential pulse polarogram of the supporting electrolyte (blank) was obtained in the range 2200 to 2800 mV before 5 successive additions of 20 mL of 1,000 mgÁmL 21 Sn(II) or Sn(IV) standard solution into the cell, in order to record the polarographic waves of 0, 2.0, 4.0, 6.0, 8.0, and 10.0 mgÁmL 21 tin concentrations. The maximum current (mA) of the waves (peak height), measured from the baseline to the top, was used to obtain the analytic curve and quantify the Sn(II) and Sn(IV) concentrations in the cold kits. The analyses were performed in triplicate, and 3 vials of each lyophilized reagent were used. The results were expressed as mean 6 SD.
The radiopharmaceutical cold kits were reconstituted by adding deaerated purified water (1.0 mL for DMSA, ECD, and pyrophosphate and 2.0 mL for MDP), and 100-, 320-, 80-, and 20-mL aliquots were separately added into the cell to determine Sn(II) or Sn(IV) in DMSA, ECD, MDP, and pyrophosphate, respectively. Sn(II) was oxidized to Sn(IV) by adding 20 mL of H 2 O 2 to the reconstituted cold kit vial and letting it stand at 37°C for 5 min. Nitrogen was bubbled through the vial for 1 min before the aliquot was withdrawn for the Sn(IV) analysis. Sn(II) and Sn(IV) were quantified using the analytic curve.
The influence of increasing concentrations of each component of the cold kit formulation on the peak height of 2.0-6.0 mgÁmL 21 Sn(II) or Sn(IV) (20-60 mL of 1,000 mgÁmL 21 tin standard solution in the cell) was evaluated. The concentration range of each component was based on the tin-tocomponent ratio of the formulation.
Titrimetric determinations for Sn(II) in DMSA, ECD, MDP, and pyrophosphate were performed using 5.0 mM I 2 (17) . where i (mA) is the current of the tin wave (peak height). The detection limits for Sn(II) and Sn(IV) were 0.21 mg mL 21 (18.6 mM) and 0.15 mg mL 21 (13.3 mM), respectively.
The wave shapes, peak heights, and potentials of the maximum current for Sn(II) or Sn(IV) were compared in the absence and in the presence of increasing concentrations of each component of the formulation. ½Fig: 2 Figure 2 shows the influence of MDP components (MDP, ascorbic acid, and pyrophosphate) on the peak height of 2.0-6.0 mgÁmL 21 (0.2-0.6 mg) Sn(II) in 3 M H 2 SO 4 and 2.0-4.0 mgÁmL 21 (0.2-0.4 mg) Sn(IV) in 3 M HCl. The abscissa was represented in a logarithmic scale. Because the SnCl 2 Á2H 2 O content in MDP was 1 mg (i.e., 0.52 mg of Sn(II)), 1:10 to 1:50 dilution factors were used to calculate the mass range of the reagents and to perform the Sn(II) and Sn(IV) analyses using the analytic curve working range. ½Table 1 Table 1 presents the Sn(II) and Sn(IV) concentrations in DMSA, ECD, MDP, and pyrophosphate considering the dilutions.
DISCUSSION
Differential pulse polarography was used for selective determination of Sn(II) and Sn(IV) in DMSA, ECD, MDP, and pyrophosphate. The SnCl 2 Á2H 2 O mass ranging from 0.125 to 2 mg covered most of the lyophilized reagent for labeling with 99m Tc used in nuclear medicine.
For a specific and selective determination of Sn(II) and Sn(IV), 3 M H 2 SO 4 was considered the most appropriate medium for Sn(II) because only Sn(II) produced a polarographic wave with the maximum current in 2370 mV (Fig.  1A) . Under the same conditions, no current could be determined for Sn(IV). In 3 M HCl, Sn(II) and Sn(IV) were electroactive and the potential of the 2 polarographic waves appeared in 2250 and 2470 mV (Fig. 1B) .
Lingane et al. reported that Sn(IV) is an air-stable form and does not produce polarographic waves either in HNO 3 or H 2 SO 4 because Sn(IV) ions are extensively hydrolyzed and precipitate as basic salts even in a highly acidic medium (4, 18) . On the other hand, HCl or bromide complexes can stabilize high-order halide complexes and produce 2 reduction waves for Sn(IV) (19) .
An investigation of the polarographic behavior of Sn(IV) in fairly concentrated H 2 SO 4 , HClO 4 , HNO 3 , or HF showed no wave in any of these media. After the addition of HCl, polarographic waves were observed for Sn(IV) and Sn(II) in a Sn(IV) solution, with an increase in the wave height without altering the half-wave potential (19) .
The adequate establishment of the supporting electrolyte allows selective determination of the ion. The polarography study of tin in various supporting electrolytes was described by Lingane et al., and the Sn(II) waves in HCl, HNO 3 , and H 2 SO 4 had a sigmoidal shape and were considered well defined for analytic use. The choice of the supporting electrolyte and the presence of stabilizing agents are the main factors that affect the reduction potential (18) . In most media, Sn(II) ions produce 2 polarographic waves. In the cathodic wave, tin is reversibly reduced to Sn(amalgam), and in the anodic wave, Sn(II) is oxidized to Sn(IV), and the degree of reversibility and suitability for analytic application is dependent on the particular medium (19) . (15) . In our work, a DMSA wave was not observed at 2200 to 2800 mV potential range. In a more complex medium such as 0.7 M KF/1.8 M KNO 3 , pH 7.7, or 0.7 M KF/0.1 M NaNO 3 , pH 7.5, proposed by Lejeune et al., Sn(II) was not affected by Sn(IV) although it was necessary to use a buffered medium and another complexing reagent such as ZnCl 2 to suppress the MDP effect (12). Decristoforo et al. proposed a simpler medium composed of methanol in 35 mM HClO 4 , and they focused their work on the evaluation of the stability of fractionated cold kits (11) . The authors observed an overlapping between Sn(II) and ECD or DMSA waves. The potential range of the peak attributed to the reduction of stannous ions to tin metal was 2350 and 2400 mV, and the reduction potential of Sn(IV) to Sn(II) was between 2150 and 2190 mV.
Before the quantification of Sn(II), the tin redox reaction taking place in the mercury drop was assessed by the presence of the components of the cold kit formulation other than the tin species. No variation was observed in the peak height, shape, and reduction potential of Sn(II) and Sn (IV) in the concentration range studied ( Figs. 2A and 2B ). Because the conclusions for DMSA, ECD, and pyrophosphate were the same, only the MDP data were presented.
The analytic curves for Sn(II) and Sn(IV) (Eqs. 1 and 2) were linear in the concentration range of 0-10 mgÁmL 21 , and the correlation coefficients (r 2 ) were greater than 0.997.
The results presented in Table 1 show that in ECD, only 65% of the total tin is present as Sn(II), indicating oxidation to Sn(IV) in the production process, which can yield a low 99m Tc labeling and poor radiochemical purity. In DMSA, MDP, and pyrophosphate, more than 87% of the total tin is in the Sn(II) oxidation state.
Even using a millimolar titrant concentration to quantify Sn(II), by the titrimetric conventional method, the titrant volumes and the Sn(II) mass in the cold kits were 0.12, 1.12, and 1.75 mL, resulting in 0.060 6 0.017, 0.607 6 0.040, and 0.953 6 0.025 mg in ECD, MDP, and pyrophosphate, respectively. Higher SD and mass results for Sn(II) by the titrimetric analysis than by the polarographic method (Table 1) can be attributed to the difficulty of visual detection of the endpoint.
CONCLUSION
The developed polarographic method was selective and adequate to determine Sn(II) even in the presence of Sn(IV) and can be used as a quality control to quantify Sn(II) and Sn(IV) in DMSA, ECD, MDP, and pyrophosphate radiopharmaceutical cold kits. 
